Global Animal Health Market: Industry Analysis & Outlook (2017-2021)

1
Industry Research by Koncept Analytics
Global Animal Health Market Industry Analysis
Outlook -----------------------------------------
(2017-2021)
September 2017
2
Executive Summary
Animals, like humans, also suffer from diseases
and hence require proper care from veterinarians,
farmers and pet owners. Improving the health of
companion animals and livestock and treating them
is the foremost objective of animal health
industry. The animal health industry can be
broadly classified into two parts - production
and companion segments. Every animal has distinct
need of its own and thus, requires different
treatments in accordance to its breed. Further,
on the basis of products, animal health market is
divided into three main sections
pharmaceuticals, biological and medicinal feed
additives. The key factors driving the growth of
animal health market include rising disposable
income, growing ageing population, increasing pet
ownership, mounting incidence of zoonotic
diseases and less stringent animal drug approval
process. Some of the noteworthy trends and
developments of this industry include mergers
acquisitions in the industry, human drugs
crossing over to the animal health and preventive
therapies. However, the expansion of animal
health market is hindered by barriers to entry
for new players, high cost of product development
and increasing pressure to reduce the use of
antibiotics in livestock. The report Global
Animal Health Market Industry Analysis Outlook
(2017-2021) provides a comprehensive analysis of
the global animal health market and its major
regional markets. Furthermore, market dynamics
such as key trends and development and
challenges are analyzed in-depth. The global
market is highly competitive consisting of
several large enterprises including Bayer AG,
Merck Co., Inc., Eli Lilly and Company and
Zoetis Inc,. The competitive landscape of the
respective market, along with the company
profiles of leading players are discussed in
detail.
3
Costs of the research, development, and approval
of new veterinary pharmaceuticals continue to
grow rapidly. Thus, many manufacturers of
veterinary drugs are looking for agents already
licensed for human use to fill their pipeline of
new products.
Global Animal Health Market by Value (2012-2016)

• In 2016, the global animal health market was
  recorded at US... billion, compared to US...
  billion in 2015, thereby depicting an annual rise
  of .
• By the end of 2021, the global animal health
  market is expected to be valued at US...
  billion, growing at a CAGR of , spanning from
  2017 to 2021.
• In 2016, the Americas dominated the global animal
  health market with share, followed by Europe
  with share.

Global Animal Health Market Forecast by Value
(2017-2021)
Global Animal Health Market Value by Region (2016)
4
During 2016, global animal health market
underwent series of changes led by major mergers
and acquisitions. Global players have been
pursuing this strategy to widen their product
portfolios, enabling them to harness market
potential in the long run.
Americas Animal Health Market Forecast by Value
(2016-2021)

• By the end of 2021, Americas animal health market
  is estimated to reach US... billion, growing at
  a CAGR of , spanning from 2016 to 2021.
• European animal health market is expected to
  reach US... billion by the end of 2021,
  increasing from US... billion in year 2016,
  depicting a CAGR of , spanning from 2016 to
  2021.
• As of 2016, parasiticides accounted for the
  largest European market share of followed by
  vaccines, antimicrobials and tropical product
  with , and shares respectively.

European Animal Health Market Forecast by Value
(2016-2021)
European Animal Health Market by Products (2016)
5
For Report Purchase Click Belowhttp//www.koncep
tanalytics.com/Researchreport/global-animal-health
-market-industry-analysis-outlook-2017-2021-24459.
aspx
Disclaimer
Contact Us
This is a licensed product of Koncept Analytics.
You cannot reproduce, publish, distribute,
publicly display, sell or create other works from
this report or use them in any way for commercial
purpose without our prior permission. Further,
you cannot copy this material, by any means
(including electronic copies), for distribution
to others unless you have purchased the corporate
license of this report. We believe the sources
are reliable, but Koncept Analytics does not
warranty the accuracy or completeness of the
data. The data presented in the report is updated
at the publication date but is subject to change
at subsequent releases. All possible efforts have
been made to ensure accuracy of data. However,
investors should not completely rely on the
information given in this report and must make
decisions based on their own investment strategy,
risk management and capital adequacy.
Koncept Analytics CS-36, First Floor, Ansal
Plaza Vaishali, Ghaziabad, U.P. 201010 T
91-120-4130959 M 91-9811715635
vikas_at_konceptanalytics.com
www.konceptanalytics.com